Healio Minute, Breast Cancer Edition: Top Headlines for the Week of November 7, 2022
Click Here to Manage Email Alerts
In this episode, data show ‘critical need’ for universal genetic testing; patients with inflammatory breast cancer at high risk for brain metastases; palbociclib fails to benefit breast cancer subgroup and more.
Read the full coverage here:
Data show ‘critical need’ for universal genetic testing of patients with breast cancer
Patients with inflammatory breast cancer at high risk for brain metastases
Palbociclib fails to benefit breast cancer subgroup, yielding lessons for future research
Low-dose aspirin does not reduce breast cancer risk
Interventions improve cancer screening rates among women in rural areas
References:
Cairat M, et al. Abstract 1840. Presented at: World Cancer Congress; Oct. 18-20, 2022; Geneva.
DeMichele A, et al. Adjuvant palbociclib for ER+ breast cancer (PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13): A preplanned analysis of the stage IIA cohort. Presented at: ASCO Plenary Series; Oct. 18, 2022.
Paskett ED, et al. Abstract 1959. Presented at: World Cancer Congress; Oct. 18-20, 2022; Geneva.
Warren LEG, et al. Cancer. 2022;doi:10.1002/cncr.34441.
Whitworth PW, et al. JAMA Netw Open. 2022;doi:10.1001/jamanetworkopen.2022.32787.
Collapse
Read more about
Click Here to Manage Email Alerts
